Evidence-based hyponatremia management in liver disease
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clin Mol Hepatol. 2023;29(4):924-944.   Published online 2023 Jun 5     DOI: https://doi.org/10.3350/cmh.2023.0090
Citations to this article as recorded by Crossref logo
Etiology, Clinical Approach, and Therapeutic Consequences of Hyponatremia
Goce Spasovski
Kidney and Dialysis.2024; 4(1): 37.     CrossRef
Association of baseline serum sodium with long-term outcomes in newly diagnosed coronary heart disease patients without heart failure: a prospective cohort study
Zelong Cao, Wenqing Zhu, Chaonan Shen, Bo Gao, Naying Jin, Fang Li, Bin Zhang, Gang Liu, Liang Zheng, Mingqi Zheng
Scientific Reports.2024;[Epub]     CrossRef
Hyponatraemia—treatment standard 2024
Goce Spasovski
Nephrology Dialysis Transplantation.2024; 39(10): 1583.     CrossRef
Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clinical and Molecular Hepatology.2023; 29(4): 1048.     CrossRef
Letter regarding “Evidence-based hyponatremia management in liver disease”
Daphne J. Theodorou, Stavroula J. Theodorou, Ioannis V. Mitselos
Clinical and Molecular Hepatology.2023; 29(4): 1043.     CrossRef
Pulmonary Complications in Patients with Liver Cirrhosis
Seul Ki Han, Soon Koo Baik, Moon Young Kim
The Korean Journal of Gastroenterology.2023; 82(5): 213.     CrossRef